Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker
The role of circulating tumor cells (CTCs) as a marker for disease progression in metastatic cancer is controversial. The current review will serve to summarize the evidence on CTCs as a marker of disease progression in patients with metastatic breast cancer. The immunohistochemistry (IHC)-based Cel...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Aurora Health Care
2014-05-01
|
Series: | Journal of Patient-Centered Research and Reviews |
Subjects: | |
Online Access: | http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1017&context=jpcrr |